Philip Morris (PM) Bets $1.2B on ZYN as BAT (BTI) Steps Up Its Pouch Push

The Bull Case: A New Home For Zyn's Growth

Aurora is PMI's archetypal greenfield manufacturing analyzable successful the US, built connected 148 acres and designed to harvester production, packaging, warehousing, and organisation successful 1 location. About $1 cardinal of the planned $1.2 cardinal has already gone into the project, and the field is expected to straight employment astir 500 radical erstwhile afloat staffed. Company estimates constituent to astir $550 cardinal successful yearly economical interaction and different 1,000 indirect jobs erstwhile it reaches afloat operation. Aurora besides joins existing PMI facilities successful Owensboro, Kentucky, and Wilson, North Carolina, expanding its fume manufacturing footprint, and arsenic per the company, the scope to export ZYN into Asia, Latin America and the Caribbean.

The timing lines up with a regulatory win. On June 30, the FDA authorized 20 ZYN products arsenic modified hazard baccy products, making ZYN the archetypal nicotine pouch allowed to marketplace itself arsenic little hazard than cigarettes. Reuters reported that Philip Morris besides bushed second-quarter estimates successful July, with the institution crediting request for its smoke-free lineup and stronger-than expected ciggratte demand, which spans ZYN, the IQOS heated-tobacco instrumentality and vapor products.

The Bear Case: Velo Max And The Price Of Scale

None of this comes cheap. The Aurora task doubled successful outgo from its archetypal $600 cardinal estimate, a reminder that scaling nicotine pouch manufacturing this accelerated requires real, and rising, superior done 2028. That spending is besides concentrated connected a azygous merchandise class conscionable arsenic the competitory tract gets much crowded. British American Tobacco (NYSE:BTI), Philip Morris's closest rival successful smoke-free nicotine, said connected July 30 that its wide New Categories gross grew 18.0% astatine changeless speech rates successful H1 2026.

Within that business, Modern Oral gross accrued 65.9%, driven partially by Velo Plus and Grizzly Modern Oral successful the US. BAT's Modern Oral portfolio reached a 39.2% measurement stock crossed its designated apical markets. BAT plans to rotation retired its higher-strength Velo Max nationally successful the US during H2 2026, aiming astatine the aforesaid support abstraction ZYN is warring for. BAT is backing that propulsion with a £1.3 cardinal stock buyback programme it says remains connected way for 2026, a motion it sees capable currency travel to money some the motorboat and shareholder returns astatine once. If Velo Max gains existent traction against ZYN conscionable arsenic Philip Morris brings its astir costly US works online, the payback play connected Aurora gets longer. Competitive unit besides exists, evident successful PMI numbers. US conception gross declined 16.5% organically successful the archetypal six months, partially due to the fact that of inventory movements and hard promotional comparisons.